ABIONYX Pharma
Biopharmaceutical company developing innovative therapies for sepsis and intensive care.
About
ABIONYX Pharma is a next-generation biopharmaceutical company focused on developing innovative therapies for sepsis and intensive care. Their approach is based on a proprietary technology platform utilizing apoA-I. Teams look it up for Biotechnology, Pharmaceuticals, Healthcare.
Frequently asked
What does ABIONYX Pharma do?
ABIONYX Pharma is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, Healthcare, Biotech. It is based in Toulouse, France and was founded in 2015. Public records show $225M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has ABIONYX Pharma raised?
ABIONYX Pharma has raised a total of $225M in funding. The most recent round on record is Capital Increase.
Where is ABIONYX Pharma headquartered?
ABIONYX Pharma is headquartered in Toulouse, France.
When was ABIONYX Pharma founded?
ABIONYX Pharma was founded in 2015.
What industry does ABIONYX Pharma operate in?
ABIONYX Pharma operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.